Methods and systems to detect and quantify the amount of LP-X and other abnormal lipoproteins in a biosample using NMR spectroscopy
US11467171B2 · kind B2 · utility
0Cited by
4References
20Claims
0Family size
Inventors
Key dates
| Filing date | Nov 13, 2018 |
| Grant date | Oct 11, 2022 |
| Priority date | — |
| Expiry date | Sep 14, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Described herein are methods and systems for the determination of constituents in biosamples by NMR spectroscopy and more specifically for the determination of lipoprotein constituents LP-X, LP-Y, and LP-Z in blood plasma and serum.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.